INSIGHTS ON SOLID DOSE MANUFACTURING
-
Don't Let Your Filling Equipment Dictate Your Drug Formulation
Gravimetric powder dosing measures true mass to eliminate equipment-driven reformulation, preserving particle design and speeding clinical development.
-
Powder Rheology: Gateway For Tablet Sticking Insights
Powder rheology offers a scientific method to predict and mitigate tablet sticking issues, helping to ensure smoother pharmaceutical production cycles through early material and tooling selection.
-
How To Fast-Track Your Oral Solid Dose To Phase 1
A strategic approach accelerates oral solid dose development by uniting molecular analysis, solubility improvement, formulation design, manufacturing efficiency, and stability testing to reach Phase 1 faster.
-
Navigating The Development Of Dry Powder For Inhalation
A CDMO-authored framework for navigating dry powder inhaler development, covering target product profile definition, API characterization, particle engineering technology selection, and encapsulation considerations.
-
6 Strategic Pillars For Selecting A Drug Packaging Partner4/14/2026
Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch.
-
Achieving Licensing For A Healthcare Solution6/16/2025
Facing strict regulations and tricky powders, a healthcare client sought an advanced filling solution. Learn how an expert collaboration led to licensed product, boosting precision and productivity.
-
How To Address Your Solid Dosage Processing Needs10/27/2025
Unlock the keys to consistent solid dosage products. Learn to align unique product needs with optimal processing requirements and equipment strategies. Gain a roadmap for improved quality and reproducibility.
-
Developing And Manufacturing Minitablets To Extend Drug Lifecycle1/27/2025
Pharmaceutical companies should leverage oral minitablets to extend drug lifecycles, optimize dosing, and improve patient-centric solutions while overcoming manufacturing challenges.
-
Practical Formulation Strategies For Poorly Soluble APIs10/2/2026
Poor aqueous solubility now defines most drug candidates in development, making early screening and solid-state assessment essential to achieving reliable exposure and avoiding costly reformulation downstream.
SOLID DOSE MANUFACTURING SOLUTIONS
-
Explore scalable technology for forming, filling, and sealing blister strips, eliminating the need for costly redevelopment when moving from clinical to commercial production volumes.
-
Discover the nanoparticle engineering, formulation and GMP manufacturing services that can drive forward your market success and unlock the power of “small."
-
Used ACG capsule filler, model AF TLab, speeds from 6000-25000 capsules/hour, 220 volt, CE design, batch# 2522/10/01, serial# 102, built 2020. includes ACG capsule polisher unit, model DP100, batch# DP62/30/21, serial# 2664, built 2020 and ACG empty capsule sorter, model ECS 100, batch# EC60/30/03, serial# 2098, built 2020.
-
Solid form screening optimizes drug properties by evaluating polymorphs, salts, and cocrystals to improve solubility, stability, and manufacturability using advanced analytics.
-
Building on the capabilities of the NP-RD10A benchtop tablet press (discussed in our previous article on USP <1062>), our services are further enhanced by the integration of the Presster™ compaction emulator. This state-of-the-art tool is designed to replicate the compaction dynamics of production tablet presses in a laboratory setting. It allows for tangible fine-tuning of the compression cycle, providing an accurate depiction of how a tablting formulation will behave under commercial manufacturing conditions. Using the Presster, Natoli Scientific can simulate full-scale production, permitting us to forecast problems before they escalate to costly production delays. Our experts can optimize the tablet design for our clients, ensuring a smooth transition from laboratory to production while adhering to the rigorous standards set by the industry including the current USP <1062> chapter.